StockMarketWire.com - Life science investment trust Syncona said it had completed the sale of its portfolio company Blue Earth Diagnostics to Bracco Imaging for $476.3m (£390.2m).
The sale of Blue Earth would generate £336.9m of net proceeds for Syncona for its 89% stake in the business.
This would further strengthen its strategic capital pool which underpinned the execution of its strategy of founding, building and funding global leaders in life science, the company said.
At 9:38am: [LON:SYNC] Syncona Ltd share price was +3p at 257p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.